Instil Bio (TIL) Asset Writedowns and Impairment (2022 - 2026)

Instil Bio's Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $31000.0 for Q4 2025.

• In Q4 2025, Asset Writedowns and Impairment fell 22.5% year-over-year to $31000.0; the TTM figure through Mar 2026 stood at $31000.0 (down 99.81% YoY), while the FY2025 annual figure was $16.6 million, up 283.82% from the prior year.
• Asset Writedowns and Impairment for Q4 2025 stood at $31000.0, down from $16.6 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $41.5 million in Q3 2023, with the low at $31000.0 in Q4 2025.
• The 4-year median for Asset Writedowns and Impairment is $1.7 million (2022), against an average of $8.5 million.
• The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment tumbled 99.76% in 2024, then surged 553.87% in 2025.
• Instil Bio's Asset Writedowns and Impairment stood at $1.7 million in 2022, then soared by 2283.69% to $41.5 million in 2023, then slumped by 99.9% to $40000.0 in 2024, then declined by 22.5% to $31000.0 in 2025.
• Business Quant data shows TIL's Asset Writedowns and Impairment at $31000.0 in Q4 2025, $16.6 million in Q1 2025, and $40000.0 in Q4 2024.